Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 week ago Contract notice

Poland - Pharmaceutical products - Purchase of chemotherapy pharmaceutical products

Original Polska - Produkty farmaceutyczne - Zakup produktów farmaceutycznych - chemioterapia

Closed Poland Warszawski stołeczny Medical equipment & pharmaceuticals

Buyer Szpital Grochowski im. dr med. Rafała Masztaka spółka z ograniczoną odpowiedzialnością

€422,236 estimated value · converted from PLN

Key facts

Closed
09:00 (UTC+2)
Procedure
Open procedure
  1. Published
  2. Deadline was
  3. Deadline was
  4. Deadline open for 17 days
  5. Awarded pending
View the official notice Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

Summary

Machine-generated summary

This tender covers successive deliveries of chemotherapy pharmaceutical products in Poland. The buyer is a healthcare provider treating patients under contracts with the National Health Fund. It is divided into eight separate lots (Cabazitaxelum, Cyclophosphamidum, Fluorouracilum, Sacituzumabum, Bicalutamidum, Capecitabinum, Abemaciclibum, Acidum zoledronicum). Bidders may submit partial offers for individual lots. Partial deliveries must be completed within three business days of order placement, and products must have a minimum shelf life of twelve months from the delivery date. The buyer commits to utilizing at least seventy-five percent of the gross contract value, depending on patient volume. No specific estimated value or submission deadline is provided.

Description

Przedmiotem zamówienia są dostawy sukcesywne produktów farmaceutycznych - chemioterapia. Opis przedmiotu zamówienia znajduje się w załączniku nr 2 do SWZ (formularz asortymentowo-cenowy). Wymagany termin realizacji dostaw częściowych: 3 dni robocze od złożenia zamówienia. Minimalny termin ważności asortymentu: 12 miesięcy od daty dostawy. Zamawiający zobowiązany będzie do wykorzystania minimum 75% wartości brutto udzielonego zamówienia. Wykorzystanie zależne będzie od liczby pacjentów zgłaszających się do Zamawiającego oraz od umów (kontraktów) z Narodowym Funduszem Zdrowia. Zamawiający dopuszcza możliwość składania ofert częściowych (8 - zadań / części zamówienia), zgodnie z podziałem określonym w załączniku nr 2 do SWZ stanowiącym Opis przedmiotu zamówienia: 1) zadanie nr 1 - Cabazitaxelum; 2) zadanie nr 2 - Cyclophosphamidum; 3) zadanie nr 3 - Fluorouracilum; 4) zadanie nr 4 - Sacituzumabum; 5) zadanie nr 5 - Bicalutamidum; 6) zadanie nr 6 - Capecitabinum; 7) zadanie nr 7 - Abemaciclibum; 8) zadanie nr 8 - Acidum zoledronicum. Cabazitaxelum, koncentrat do sporządzania roztworu do infuzji, 10 mg/ml; Cyclophosphamidum, koncentrat do sporządzania roztworu do wstrzykiwań / do infuzji, 100 mg/ml; Fluorouracilum, roztwór do wstrzykiwań i infuzji, 500 mg sporządzania roztworu do infuzji, 5 mg/ml; Sacituzumabum govitecanum, proszek do sporządzania koncentratu roztworu do infuzji, 200 mg; Bicalutamidum, tabl. powl.; Capecitabinum, tabl. powl., 150 mg, 500 mg; Abemaciclibum, tabl. powl., 50 mg, 100 mg, 150 mg; Acidum zoledronicum

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago

Szpital Grochowski im. dr med. Rafała Masztaka spółka z ograniczoną odpowiedzialnością

Poland

notices in the register
218
awards
101
awarded in total
€19.1M

Who wins its contracts

Many suppliers
different companies won its awards
70
of the awards went to the three most frequent winners
18%
of its calls state an estimated value
80%

Based on 89 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.5
of those lots received a single tender
67%
of the awards went to companies based in another country
1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Awards most often to

  1. Jol-Mark Sp. z o.o. 9 awards €379,587
  2. URTICA Sp. z o.o. 5 awards €825,306
  3. Medtronic Poland Sp. z o.o. 2 awards €1.6M

2 open tenders right now

Market context

open now in Medical equipment & pharmaceuticals
8,434
median open notice
€300,000

Who wins in this market

Many suppliers

Poland · Medical equipment & pharmaceuticals

different companies won awards here
13,478
of the awards went to the three most frequent winners
4%
buyers awarded contracts here
1,464

Based on 23,086 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.8
of those lots received a single tender
63%
of the awards went to companies based in another country
2%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Read before bidding
    Estimated value
    Was: €429,217
    Now: €422,236 -2%
    Submission deadline
    Was: July 19, 2026, 22:00
    Now: July 20, 2026, 07:00 1 day later
  2. Act now
    Status
    Was: Open
    Now: Closed
    Estimated value
    not stated
    Now: €429,217
    Submission deadline
    Was: July 20, 2026, 00:00
    Now: July 20, 2026, 00:00 1 day earlier
    Scope and criteria
    The description was expanded. Re-read it before you bid.
    Estimated value
    not stated
    Now: €1,848,338

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Open now

Awarded before

Never miss a tender like this

985 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language